Healthcare · Diagnostics Research · NYSE
| Market cap | $25.91B |
|---|---|
| Trailing P/E | 22.1 |
| FCF yield | 5.1% |
| Revenue growth (YoY) | +11.8% |
| EPS growth (YoY) | +10.4% |
| FCF/share growth (YoY) | +49.5% |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Diagnostics Research |
Quest Diagnostics Incorporated trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Carol Devine Miller | House | Sell | $15,001 - $50,000 | Aug 13, 2026 |
| Julie Johnson | House | Sell | $1,001 - $15,000 | Aug 5, 2026 |
| Alan Armstrong | Senate | Buy | $1,001 - $15,000 | Jul 21, 2026 |
| Alan Armstrong | Senate | Buy | $1,001 - $15,000 | Jul 21, 2026 |
| Alan Armstrong | Senate | Buy | $1,001 - $15,000 | Jul 21, 2026 |
| Alan Armstrong | Senate | Buy | $1,001 - $15,000 | Jul 21, 2026 |
| Julia Letlow | House | Sell | $1,001 - $15,000 | Jan 13, 2026 |
| Julia Letlow | House | Buy | $1,001 - $15,000 | Jan 13, 2026 |
| Julie Johnson | House | Sell | $1,001 - $15,000 | Dec 11, 2025 |
| Carol Devine Miller | House | Sell | $1,001 - $15,000 | Apr 11, 2025 |
| Earl Blumenauer | House | Sell | $1,001 - $15,000 | May 4, 2024 |
| Thomas R Carper | Senate | Buy | $1,001 - $15,000 | — |